Per thor Straten National Center for Cancer Immune Therapy, Department of Oncology University Hospital Herlev Biography Publications Institution JoVE Articles Per thor Straten has not added a biography. If you are Per thor Straten and would like to personalize this page please email our Author Liaison for assistance. Publications Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens Frontiers in Immunology. 2021 | Pubmed ID: 34149689 TAM Receptor Inhibition-Implications for Cancer and the Immune System Cancers. Mar, 2021 | Pubmed ID: 33801886 The Capacity of CD4 Vγ9Vδ2 T Cells to Kill Cancer Cells Correlates with Co-expression of CD56 Cytotherapy. 07, 2021 | Pubmed ID: 33785258 Vaccination Against RhoC Induces Long-lasting Immune Responses in Patients with Prostate Cancer: Results from a Phase I/II Clinical Trial Journal for Immunotherapy of Cancer. 11, 2020 | Pubmed ID: 33184050 Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet Frontiers in Immunology. 2020 | Pubmed ID: 32983105 Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo International Journal of Molecular Sciences. May, 2020 | Pubmed ID: 32471301 TAM-ing T Cells in the Tumor Microenvironment: Implications for TAM Receptor Targeting Cancer Immunology, Immunotherapy : CII. Feb, 2020 | Pubmed ID: 31664482 MERTK Acts As a Costimulatory Receptor on Human CD8 T Cells Cancer Immunology Research. Sep, 2019 | Pubmed ID: 31266785 Collagen Density Regulates the Activity of Tumor-infiltrating T Cells Journal for Immunotherapy of Cancer. 03, 2019 | Pubmed ID: 30867051 Publisher Correction: Actively Personalized Vaccination Trial for Newly Diagnosed Glioblastoma Nature. 02, 2019 | Pubmed ID: 30733620 Actively Personalized Vaccination Trial for Newly Diagnosed Glioblastoma Nature. 01, 2019 | Pubmed ID: 30568303 Chemokine Receptor Engineering of T Cells with CXCR2 Improves Homing Towards Subcutaneous Human Melanomas in Xenograft Mouse Model Oncoimmunology. 2018 | Pubmed ID: 30221044 Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site Cells. Aug, 2018 | Pubmed ID: 30126117 Improved Migration of Tumor Ascites Lymphocytes to Ovarian Cancer Microenvironment by CXCR2 Transduction Oncoimmunology. 2018 | Pubmed ID: 29632724 Future Perspectives in Melanoma Research "Melanoma Bridge", Napoli, November 30th-3rd December 2016 Journal of Translational Medicine. 11, 2017 | Pubmed ID: 29145885 Exercise and Cancer: from "healthy" to "therapeutic"? Cancer Immunology, Immunotherapy : CII. May, 2017 | Pubmed ID: 28324125 Exercise: A New Role for an Old Tool Molecular & Cellular Oncology. Jul, 2016 | Pubmed ID: 27652317 Transfection of Tumor-Infiltrating T Cells with MRNA Encoding CXCR2 Methods in Molecular Biology (Clifton, N.J.). 2016 | Pubmed ID: 27236805 Tryptophan 2,3-dioxygenase (TDO)-reactive T Cells Differ in Their Functional Characteristics in Health and Cancer Oncoimmunology. Jan, 2015 | Pubmed ID: 25949861 Broadening the Repertoire of Melanoma-associated T-cell Epitopes Cancer Immunology, Immunotherapy : CII. May, 2015 | Pubmed ID: 25854582 Spontaneous Presence of FOXO3-specific T Cells in Cancer Patients Oncoimmunology. 2014 | Pubmed ID: 25960934 Correlation Between Frequencies of Blood Monocytic Myeloid-derived Suppressor Cells, Regulatory T Cells and Negative Prognostic Markers in Patients with Castration-resistant Metastatic Prostate Cancer Cancer Immunology, Immunotherapy : CII. Nov, 2014 | Pubmed ID: 25085000 T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2014 | Pubmed ID: 24526738 Clonal Expansion of Renal Cell Carcinoma-infiltrating T Lymphocytes Oncoimmunology. Sep, 2013 | Pubmed ID: 24228230 High Frequency of T Cells Specific for Cryptic Epitopes in Melanoma Patients Oncoimmunology. Jul, 2013 | Pubmed ID: 24073381 Characterization of Spontaneous Immune Responses Against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot Cells. Apr, 2012 | Pubmed ID: 24710413 Association of a Functional Indoleamine 2,3-dioxygenase 2 Genotype with Specific Immune Responses Oncoimmunology. Jul, 2012 | Pubmed ID: 22754762 Parallel Detection of Antigen-specific T Cell Responses by Combinatorial Encoding of MHC Multimers Nature Protocols. Apr, 2012 | Pubmed ID: 22498709 Dissection of T-cell Antigen Specificity in Human Melanoma Cancer Research. Apr, 2012 | Pubmed ID: 22311675 Generation of Autologous Tumor-specific T Cells for Adoptive Transfer Based on Vaccination, in Vitro Restimulation and CD3/CD28 Dynabead-induced T Cell Expansion Cancer Immunology, Immunotherapy : CII. Aug, 2012 | Pubmed ID: 22237888 Tumor Associated Antigen Specific T-cell Populations Identified in Ex Vivo Expanded TIL Cultures Cellular Immunology. 2012 | Pubmed ID: 22230732 Immunotherapy for Metastatic Colorectal Cancer: Present Status and New Options Scandinavian Journal of Gastroenterology. Mar, 2012 | Pubmed ID: 22214467 Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application Journal of Skin Cancer. 2011 | Pubmed ID: 21773037 Identification of a Cyclin B1-derived CTL Epitope Eliciting Spontaneous Responses in Both Cancer Patients and Healthy Donors Cancer Immunology, Immunotherapy : CII. Feb, 2011 | Pubmed ID: 20981424 Longitudinal Immune Monitoring of Patients Receiving Intratumoral Injection of a MART-1 T-cell Receptor-transduced Cell Line (C-Cure 709) Cytotherapy. 2009 | Pubmed ID: 19530030 CD8 T-cell Responses Against Cyclin B1 in Breast Cancer Patients with Tumors Overexpressing P53 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2009 | Pubmed ID: 19223507 Sanntidsovervåking av mitokondrie respirasjon i cytokin-differensierte humane primære T-celler Kasper Mølgaard*1, Anne Rahbech*1, Özcan Met1, Inge Marie Svane1, Per thor Straten1,3, Claus Desler2, Marlies J. W. Peeters1 1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev, 2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, 3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen JoVE 62984 Immunology and Infection
Sanntidsovervåking av mitokondrie respirasjon i cytokin-differensierte humane primære T-celler Kasper Mølgaard*1, Anne Rahbech*1, Özcan Met1, Inge Marie Svane1, Per thor Straten1,3, Claus Desler2, Marlies J. W. Peeters1 1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev, 2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, 3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen JoVE 62984 Immunology and Infection
